INCT 1216

Study Name
INCT 1216
Clinical Trial Category (check all that apply)
  • Beyond First Line Therapy
  • Targeted Therapy
Study Center
Institution Name
Cleveland Clinic
Institution Address
9500 Euclid Avenue
City
Cleveland
State
Ohio
Zip Code
44195
Study Contacts
Principal Investigator
Dr.Davendra Sohal
P.I. Phone
(216) 444-8258
P.I. Email
sohald@ccf.org
Study Coordinator
Sarah Viviani
Study Coordinator Phone
(216) 444-8258
Study Coordinator Email
VIVIANS@ccf.org
OVERVIEW – in layman’s terms (150 words max)
A Clinical trial to study the efficacy and safety of INCB054828 in patients with Advanced/Metastatic or surgically unresectable cholangiocarcinoma with FGFR2 translocations, other FGF/FGFR alterations or negative FGF/FGFR alterations who failed previous therapy.
Enrollment
0
Study Start Date
10/19/2017
Estimated Completion Date
12/18/2018
Translate »

Pin It on Pinterest